Medicamen Biotech Share Price
NSE: MEDICAMEQ|BSE: 531146|Pharmaceuticals₹334.00
+₹0.60 (0.18%) As on 19 Sep, 2025 | 15:29 ISTMedicamen Biotech Stock Performance
Market cap  ₹453 Crs | Open ₹335.30 | Prev. Close ₹333.40 |
Circuit range ₹400.80 - ₹267.20 | Day range ₹331.00 - ₹338.00 | Year range ₹330.00 - ₹630.00 |
Volume 8,601 | Avg. traded ₹334.42 | Revenue (12m) ₹163 Crs |
About Medicamen Biotech
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.
As of last trading day, Medicamen Biotech opened at ₹335.30 and last traded at ₹334.00, showing a rise of 0.60 points (0.18%) compared to the previous close of ₹333.40. During the session, the stock touched a high of ₹338.00 and a low of ₹331.00. The company's market capitalization now stands at ₹453 Crs, with a P/E ratio of 64.8 and a dividend yield of 0.21%.
21 September 2025 – Medicamen Biotech Share Price Update
As of last trading day, Medicamen Biotech opened at ₹335.30 and last traded at ₹334.00, showing a rise of 0.60 points (0.18%) compared to the previous close of ₹333.40. During the session, the stock touched a high of ₹338.00 and a low of ₹331.00. The company's market capitalization now stands at ₹453 Crs, with a P/E ratio of 64.8 and a dividend yield of 0.21%.Medicamen Biotech Share Price Chart
₹334.00+₹0.60 (0.18%)
Please wait...
Medicamen Biotech Key Indicators
P/E ratio 64.83 | P/B ratio 2.81 | ROE 4.43% |
ROCE 6.71% | Dividend yield 0.21% | Debt/Equity ratio 0.13 |
EPS 7.44 |
Investment Checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Medicamen Biotech Financial Ratios
Operating profit margin15.41% | Net profit margin6.24% |
ROE4.43% | ROA3.82% |
ROCE6.71% |
Quick ratio1.26 | Current ratio2.01 |
Interest coverage4.55 | Asset turnover0.69 |
Debt to Equity0.13 |
P/E ratio64.83 | P/B ratio2.81 |
EV / EBITDA27.26 | |
Dividend yield0.21% |
Medicamen Biotech Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-25 | ₹168.79 | ₹9.88 | ₹6.56 |
Mar-24 | ₹181.64 | ₹13.08 | ₹9.49 |
Mar-23 | ₹143.33 | ₹17.05 | ₹14.73 |
Mar-22 | ₹117.17 | ₹18.09 | ₹14.90 |
Medicamen Biotech Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-25 | ₹-8.16 | ₹-1.4 | ₹-1.47 |
Mar-24 | ₹-6.74 | ₹-5.56 | |
Mar-23 | ₹-6.29 | ₹-5.88 | |
Mar-22 | ₹-8.47 |
Medicamen Biotech Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-25 | ₹297.15 | ₹84.10 |
Mar-24 | ₹294.55 | ₹87.57 |
Mar-23 | ₹278.52 | ₹85.10 |
Mar-22 | ₹225.69 | ₹79.22 |
Medicamen Biotech Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
05-Sep-25 | ₹349.70 | ₹350.40 | |
04-Sep-25 | ₹354.05 | ₹346.60 | -1.13% |
03-Sep-25 | ₹352.35 | ₹350.55 | |
02-Sep-25 | ₹350.00 | ₹350.55 | |
01-Sep-25 | ₹349.00 | ₹347.00 | |
29-Aug-25 | ₹341.70 | ₹345.25 | |
28-Aug-25 | ₹350.10 | ₹344.30 | -1.66% |
26-Aug-25 | ₹350.95 | ₹350.10 |
Medicamen Biotech Corporate Actions
Dividend • ₹1/share
Ex date 19 Sep 2025
Dividend • ₹1/share
Ex date 19 Sep 2024
Dividend • ₹1/share
Ex date 20 Sep 2023
Stocks Similar to Medicamen Biotech
Stock Name | Price | Change % |
|---|---|---|
| Bajaj Healthcare | ₹423.65 | -₹3.15 (-0.74%) |
| Kopran | ₹172.42 | -₹0.34 (-0.2%) |
| Neuland Lab | ₹15,467.00 | -₹406.00 (-2.56%) |
| NGL Fine Chem | ₹1,412.90 | +₹53.30 (3.92%) |
| ORCHID PHARMA | ₹788.45 | +₹71.65 (10.00%) |
| Panacea Biotec | ₹427.45 | -₹18.50 (-4.15%) |
| SMS Pharmaceuticals | ₹292.14 | +₹6.76 (2.37%) |
| Suven Life Sciences | ₹224.45 | +₹5.46 (2.49%) |
| Unichem Laboratories | ₹502.95 | -₹3.90 (-0.77%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| Indian Railway Finance Corp Share Price | ₹129.69 | +₹0.40 (0.31%) |
| Indian Railway Tourism Corp Share Price | ₹736.60 | +₹1.20 (0.16%) |
| ITC Share Price | ₹410.65 | -₹0.90 (-0.22%) |
| JIO FIN SERVICES LTD Share Price | ₹317.00 | -₹0.35 (-0.11%) |
| Reliance Share Price | ₹1,407.40 | -₹7.60 (-0.54%) |
| Tata Motors Share Price | ₹707.45 | -₹3.75 (-0.53%) |
| Tata Power Share Price | ₹396.30 | +₹3.20 (0.81%) |
| Tata Steel Share Price | ₹171.48 | -₹0.55 (-0.32%) |
| Vodafone Idea Share Price | ₹8.40 | +₹0.56 (7.14%) |
| YES Bank Share Price | ₹21.17 | +₹0.10 (0.47%) |
Medicamen Biotech News
Medicamen Biotech Share Price FAQs
What is the share price of Medicamen Biotech today?
Medicamen Biotech share price is ₹ 334.00 as on Sep, 2025 | 15:29 IST.
What are the high & low stock price of Medicamen Biotech today?
Medicamen Biotech stock price hit a high of ₹ 338.00 and low of ₹ 331.00 as on Sep, 2025 | 15:29 IST.
What is the market cap of Medicamen Biotech?
The market cap of Medicamen Biotech is ₹ 453.00 Crores as on Sep, 2025 | 15:29 IST.
What are the the 52-week high and low share prices of Medicamen Biotech stock on the NSE?
52-week high stock Price of Medicamen Biotech is ₹ 630.00 and Low Price is ₹ 330.00 as on Sep, 2025 | 15:29 IST.
What are the stock symbols of Medicamen Biotech?
The stock symbol of Medicamen Biotech is NSE: MEDICAMEQ on the NSE, BSE: 531146 on the BSE, and the ISIN is INE646B01010.
Can I buy Medicamen Biotech shares on Holidays?
No, shares of Medicamen Biotech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Medicamen Biotech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy Medicamen Biotech shares?
To buy Medicamen Biotech shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of Medicamen Biotech?
The PE and PB ratio of Medicamen Biotech is 64.83 and 2.81 respectively, as on Sep, 2025 | 15:29 IST.
What are the returns on Medicamen Biotech shares?
The historical returns for Medicamen Biotech shares are -25.27 for 1 year, -68.97 for 3 year and -39.49 for 5 year.